smartRNA
smartRNA is developing a small RNA-based platform technology for treating monogenic diseases caused by reduced protein levels, primarily haploinsufficiency disorders, which constitute a significant unmet medical need
Project summary
Purpose
To develop a small RNA-based platform technology for treating monogenic diseases caused by reduced protein levels.
Host university
Aarhus University (AU)
Funding per year
DKK 6,5M
Duration
Three years
Expected outcome
Viable startup that can raise seed or Series A financing
Project leaders
See who heads the smartRNA project on its mission to develop a small RNA-based platform technology for treating monogenic diseases caused by reduced protein levels.
“This innovative approach has the potential to transform the treatment landscape for haploinsufficiency diseases and to make a significant societal impact, offering hope and improved outcomes for patients worldwide.”
Anja Mølhart Høg
Entrepreneur in Residence